Richard Horuk Selected Research

Richard Horuk Research Topics

Disease

9	Inflammation (Inflammations) 06/2013 - 12/2004
7	Fibrosis (Cirrhosis) 07/2011 - 01/2002
6	Autoimmune Diseases (Autoimmune Disease) 08/2011 - 09/2005
5	Neoplasms (Cancer) 05/2014 - 03/2005
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2014 - 01/2009
4	Multiple Sclerosis 09/2009 - 02/2003
3	Rheumatoid Arthritis 04/2015 - 07/2005
3	Infections 07/2010 - 02/2007
2	Atherosclerosis 04/2015 - 06/2012
2	Asthma (Bronchial Asthma) 05/2014 - 08/2011
2	Atrophy 04/2005 - 12/2004
2	Proteinuria 12/2004 - 06/2004
1	Type 2 Diabetes Mellitus (MODY) 08/2011
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2011
1	Pneumonia (Pneumonitis) 07/2011
1	Malaria 07/2010
1	Communicable Diseases (Infectious Diseases) 01/2009
1	Virus Diseases (Viral Diseases) 01/2009
1	Reperfusion Injury 12/2008
1	Nephritis 11/2008
1	Albuminuria 11/2008
1	Sepsis (Septicemia) 04/2007
1	Pancreatitis 03/2007
1	Lung Injury 03/2007
1	Disease Progression 03/2007
1	Myocarditis (Carditis) 06/2006
1	Osteolysis 01/2006
1	HIV Infections (HIV Infection) 01/2006
1	Multiple Myeloma 03/2005
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 12/2004
1	Sclerosis 12/2004
1	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2004
1	Glomerulonephritis 06/2004
1	Renal Insufficiency (Renal Failure) 06/2004
1	Lupus Nephritis 06/2004
1	Ureteral Obstruction 02/2004
1	Alzheimer Disease (Alzheimer's Disease) 11/2003
1	Amyloid Plaque 11/2003

Drug/Important Bio-Agent (IBA)

13	Chemokine ReceptorsIBA 04/2015 - 01/2002
12	ChemokinesIBA 06/2013 - 01/2002
9	BX 471IBA 09/2007 - 01/2002
7	LigandsIBA 06/2012 - 07/2005
5	Pharmaceutical PreparationsIBA 05/2014 - 01/2002
4	CCR1 ReceptorsIBA 07/2011 - 07/2005
4	CollagenIBA 07/2011 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 01/2009 - 01/2002
3	Messenger RNA (mRNA)IBA 11/2008 - 01/2002
2	Maraviroc FDA Link 01/2014 - 02/2009
2	CCR ReceptorsIBA 07/2011 - 12/2004
2	Chemokine CCL3IBA 07/2011 - 03/2005
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2009 - 01/2009
2	Indicators and Reagents (Reagents)IBA 04/2007 - 03/2007
1	mogamulizumabIBA 05/2014
1	NucleotidesIBA 05/2014
1	Monoclonal AntibodiesIBA 05/2014
1	plerixafor FDA Link 01/2014
1	CCR2 ReceptorsIBA 08/2011
1	CyclohexanesIBA 08/2011
1	CC ChemokinesIBA 07/2011
1	Hydroxyproline (4 Hydroxyproline)IBA 07/2011
1	Chloroquine (Aralen)FDA LinkGeneric 07/2010
1	Antimalarials (Antimalarial Agents)IBA 07/2010
1	AntigensIBA 07/2010
1	Estrogen Receptor alphaIBA 09/2009
1	Estrogens (Estrogen)FDA Link 09/2009
1	Interleukin-17 (Interleukin 17)IBA 09/2009
1	CytokinesIBA 09/2009
1	Estrogen Receptor betaIBA 09/2009
1	Estrogen ReceptorsIBA 09/2009
1	Biological ProductsIBA 01/2009
1	Chemotactic FactorsIBA 01/2009
1	A 7 (A-7)IBA 12/2008
1	CeruletideIBA 03/2007
1	Peroxidase (Myeloperoxidase)IBA 03/2007
1	Peptides (Polypeptides)IBA 02/2007
1	Cardiac MyosinsIBA 06/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2004
1	DNA (Deoxyribonucleic Acid)IBA 06/2004
1	AutoantibodiesIBA 06/2004
1	Antigen-Antibody Complex (Immune Complex)IBA 06/2004
1	Amyloid beta-PeptidesIBA 11/2003
1	SynaptophysinIBA 11/2003
1	CCR8 ReceptorsIBA 02/2003

Therapy/Procedure

2	Therapeutics 05/2014 - 07/2010
2	Ligation 04/2007 - 01/2002
1	Transplantation 01/2014
1	Hematopoietic Stem Cell Mobilization 01/2014
1	Punctures 04/2007
1	Intraperitoneal Injections 03/2007
1	Intravenous Injections 12/2004